We believe that the pharmaceutical business is today poised for a great leap forward. Truly innovative technologies with the potential to change the nature of human health and longevity have already appeared and each day brings better and better innovations. At the same time, the fruits of these discoveries are becoming prohibitively unaffordable for the majority of the human race. There is a desperate need for solutions that emerge out of these innovative technologies to reach the common man at an affordable cost so that these benefits do not remain accessible only to the rich and affluent sections of society.
Ever changing regulatory guidelines, advance in drug therapy and delivery systems, drug industry mergers aquisitions, globalisation and evolving markets such as those for nutritional supplements, old age and alternative therapy medicines pose challenges to every pharmaceutical organisation to manage and accelerate the drug development process.